Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Measles virus, one of the most contagious of all human viruses, has been largely contained by the development and use of a vaccine that was introduced 50 years ago. These two volumes were timed to honor the introduction of the vaccine and to record the enormous advancements made in understanding the molecular and cell biology, pathogenesis, and control of this infectious disease. Where vaccine has been effectively delivered, endemic measles virus transmission has been eliminated. However, difficulties in vaccine delivery, lack of health care support and objection to vaccination in some communities continue to result in nearly 40 million cases and over 300,000 deaths per year from measles.

Measles -- Vaccination. --- Measles virus. --- Measles. --- Medical virology. --- Medicine. --- Morbilli virus (Measles virus) --- Virology. --- Biomedicine. --- Microbiology --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Morbilliviruses --- Medical microbiology --- Virology --- Virus diseases

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Immunology. Immunopathology --- MEDICAL --- Infectious Diseases --- Viral Vaccines --- Bacterial Vaccines --- Vaccines --- Biological Products --- Complex Mixtures --- Chemicals and Drugs --- Pertussis Vaccine --- Rubella Vaccine --- Biology --- Health & Biological Sciences --- Microbiology & Immunology --- Pertussis vaccines --- Rubella vaccines --- Whooping cough --- Rubella --- Side effects --- Vaccination --- Complications --- Fourth disease --- German measles --- Measles, German --- Rosella --- Röteln --- Rubeola notha --- Three-day measles --- Pertussis --- Bordetella pertussis vaccines --- Pertussis vaccine --- Whooping cough vaccines --- Togavirus infections --- Cough --- Gram-negative bacterial infections --- Respiratory infections --- Viral vaccines --- Bacterial vaccines

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Immunization. --- Vaccination --- Immunization --- Autism --- Measles-Mumps-Rubella Vaccine --- Safety --- Autistic Disorder --- Mumps Vaccine --- Immunologic Techniques --- Vaccines, Combined --- Measles Vaccine --- Communicable Disease Control --- Primary Prevention --- Rubella Vaccine --- Accident Prevention --- Child Development Disorders, Pervasive --- Immunotherapy --- Viral Vaccines --- Public Health Practice --- Vaccines --- Accidents --- Preventive Health Services --- Investigative Techniques --- Mental Disorders Diagnosed in Childhood --- Immunomodulation --- Public Health --- Biological Products --- Biological Therapy --- Health Services --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Mental Disorders --- Complex Mixtures --- Health Care Facilities, Manpower, and Services --- Environment and Public Health --- Therapeutics --- Psychiatry and Psychology --- Health Care --- Chemicals and Drugs --- Public Health - General --- Health & Biological Sciences --- Complications --- Autism. --- Complications. --- Autistic disorder --- Complications and sequelae --- Side effects --- Autism spectrum disorders --- Hyperlexia

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Black women have higher rates of premature birth than other women in America. This cannot be simply explained by economic factors, with poorer women lacking resources or access to care. Even professional, middle-class black women are at a much higher risk of premature birth than low-income white women in the United States. Dána-Ain Davis looks into this phenomenon, placing racial differences in birth outcomes into a historical context, revealing that ideas about reproduction and race today have been influenced by the legacy of ideas which developed during the era of slavery. While poor and low-income black women are often the "mascots" of premature birth outcomes, this book focuses on professional black women, who are just as likely to give birth prematurely. Drawing on an impressive array of interviews with nearly fifty mothers, fathers, neonatologists, nurses, midwives, and reproductive justice advocates, Dána-Ain Davis argues that events leading up to an infant's arrival in a neonatal intensive care unit (NICU), and the parents' experiences while they are in the NICU, reveal subtle but pernicious forms of racism that confound the perceived class dynamics that are frequently understood to be a central factor of premature birth. The book argues not only that medical racism persists and must be considered when examining adverse outcomes--as well as upsetting experiences for parents--but also that NICUs and life-saving technologies should not be the only strategies for improving the outcomes for black pregnant women and their babies. Davis makes the case for other avenues, such as community-based birthing projects, doulas, and midwives, that support women during pregnancy and labor are just as important and effective in avoiding premature births and mortality. -- Provided by publisher. A troubling study of the role that medical racism plays in the lives of black women who have given birth to premature and low birth weight infants. -- Provided by publisher. "'Reproductive Injustice: Racism, Pregnancy, and Premature Birth' explores the issues of racism, medicine, and motherhood"--

Race discrimination --- African American women --- Discrimination in medical care --- Reproductive health services --- Reproductive Health Services --- African Americans --- Racism --- Health aspects --- Medical care --- Social aspects --- United States. --- Baby Doe rules. --- Black feminist framework. --- Children’s Bureau. --- German measles. --- March of Dimes. --- NICU. --- NICUs. --- Sheppard-Towner Act. --- afterlife of slavery. --- birth stories. --- birth workers. --- comprehensive care. --- definition of prematurity. --- diagnostic lapse. --- doula. --- doulas. --- etiology. --- hardy babies. --- labor. --- medical encounters. --- medical racism. --- midwives. --- misdiagnosis. --- model of care. --- neonatal intensive care unit. --- neonatologists. --- obstetric hardiness. --- polio. --- premature birth. --- preventive approaches. --- race and pregnancy. --- racial disparity. --- racial politics. --- racial science. --- racism. --- technologies of saving. --- temporality.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Antiviral agents are used for the treatment of viral diseases. Antiviral drugs have been successfully developed and used clinically for a limited number of important human viral diseases notably caused by human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), herpes, and influenza viruses. Despite the successes of these antiviral drugs, issues with drug resistance and toxicity remain challenging. These challenges are driving research to identify new drug candidates and to investigate novel drug targets to develop new mechanistic drug classes. Antiviral agents are not available against many viruses that cause human disease and economic burdens; in particular, the development of antiviral agents against emerging, re-emerging, and neglected viruses is increasingly becoming a priority. This book includes six review articles that discuss new antiviral strategies. The reviews either discuss advances relating to a specific virus or new therapeutic targets and approaches. The book includes 15 original research articles reporting new antiviral agents against a variety of clinically and economically important viruses and studies into the prevalence or acquisition of drug resistance. Overall, this book is an exciting collection of new research and ideas relating to the development of antiviral agents.

Zika virus --- nucleoside analogues --- antiviral agents --- NS5 --- prodrugs --- ProTides --- neural stem cells --- RNA-dependent RNA polymerase --- cytomegalovirus --- latent infection --- TALEN --- Surveyor nuclease mutation detection assay --- ie-1 gene --- quantitative real-time PCR --- Epstein–Barr virus --- herpes viruses --- lytic gene expression --- Burkitt lymphoma cells --- clozapine --- antipsychotic drug --- antiviral drug --- enteroviruses --- coxsackievirus B4 --- persistent infection --- fluoxetine --- resistance --- mutations --- herpes B virus --- macacine herpesvirus-1 --- genistein --- flavonoids --- acyclovir --- ganciclovir --- Plantago asiatica --- Clerodendrum trichotomum --- RSV --- therapeutic effects --- acteoside --- human antimicrobial peptides --- antiviral strategies --- defensins --- cathelicidins --- hepcidins --- transferrins --- influenza A virus --- brevilin A --- antiviral --- sesquiterpene lactone --- replication --- PRRSV --- polyethylenimine --- PEI --- virion internalization --- endocytosis --- HIV --- pediatrics --- Ethiopia --- pre-treatment drug resistance --- combination antiretroviral therapy (cART) --- dried plasma spots --- dried blood spots --- sphingolipids --- glycosphingolipids --- viruses --- lipid biosynthesis --- flavivirus --- Japanese encephalitis virus --- furin inhibitor --- precursor membrane protein --- measles virus --- central nervous system --- tropism --- treatments --- porcine reproductive and respiratory syndrome virus --- ginsenoside Rg1 --- antiviral activity --- pro-inflammatory factor --- NF-κB signaling pathway --- acute/latent infection --- congenital infection --- antiviral agent --- therapeutic strategies --- nucleic acid-based therapeutic approach --- HCMV vaccine --- adoptive cell therapy --- Rev response element --- chemical footprinting --- SHAPE --- drug discovery --- branched peptides --- herpesvirus --- immediate-early --- IE1 --- IE2 --- ribozyme --- RNA interference --- CRISPR/Cas --- small molecule --- orthohantavirus --- phenyl-benzotriazoles --- C-FRA --- Porcine circovirus type 2 --- epigallocatechin gallate --- heparan sulfate --- antiviral effect --- virus attachment --- microvirin --- lectin --- human immunodeficiency virus --- hepatitis C virus --- antiviral inhibitor --- non-immunogenic --- viral entry --- protein drugs --- LUMS1 --- oleanane-type derivatives --- influenza A virus (IAV) --- virus entry inhibitors --- hemagglutinin (HA) --- n/a --- Epstein-Barr virus